1000/1000
Hot
Most Recent
Ovarian cancer (OCa) is characterized as one of the common reasons for cancer-associated death in women globally. This gynecological disorder is chiefly named the “silent killer” due to lacking an association between disease manifestations in the early stages and OCa.
Type of Nano-Based Herbal Formulation | Mechanism/Effect | In Vivo/In Vitro | References |
---|---|---|---|
PLGA-phospholipid-PEG nanoparticles comprising curcumin | Downregulation of P-glycoprotein | In vitro | [45] |
Niosome-encapsulated curcumin | Arresting the cell cycle at the S phase and apoptosis induction | In vitro | [46] |
Docetaxel curcumin/methoxy poly (ethylene glycol)- poly (L-lactic acid) (MPEG-PLA) copolymers nanomicelles |
Suppression of tumor proliferation and angiogenesis | In vivo/in vitro | [47] |
Curcumin—loaded nanostructured lipid carrier | Reduction of cell colony survival, inhibition of tumor growth, and apoptosis induction | In vitro | [48] |
Gemini curcumin | Apoptosis induction | In vitro | [49] |
Curcumin and paclitaxel co-delivery by hyaluronic acid-modified drug-loaded polyethylenimine and stearic acid | Downregulation of P-glycoprotein, and suppression of tumor cell migration | In vivo/in vitro | [50] |
Dendrosomal nano-curcumin | Reduction of cancer cell viability, decease of LncRNAs expression of H19 and HOTAIR, and increase in the expression of MEG3 LncRNA and Bcl2 protein | In vitro | [51] |
Co-use of curcumin nanoparticles and Cisplatin | Decrease of ovarian tumor weight and volume, reduction of PI3K, TGF-β, JAK, and Ki67 expression, Akt and STAT3 phosphorylation, and decrease of IL-6 level | In vivo/in vitro | [44] |
Encapsulated quercetin into monomethoxy poly (ethylene glycol)- poly (3-caprolactone) |
Apoptosis induction and the suppression of angiogenesis | In vivo/in vitro | [52] |
Encapsulated quercetin into methoxypoly(ethylene glycol) Poly(caprolactone) | Apoptosis induction and cell growth suppression | In vivo/in vitro | [53] |
PEGylated liposomal quercetin | Apoptosis induction, cell proliferation inhibition, and arresting the cell cycle at G0/G1 and G2/M phases | In vivo/in vitro | [54] |
Resveratrol—ZnO nanohybrid | Mitochondrial membrane depolarization and ROS formation | In vitro | [55] |
RGD-conjugated Resveratrol human serum albumin nanoparticles | Reduction of cell viability and tumor growth inhibition | In vivo/in vitro | [56] |
Resveratrol—bovine serum albumin nanoparticles |
Reduction of cancer cell growth, activation of cytochrome C, upregulation of caspase-3 and caspase-3 expression |
In vivo/in vitro | [57] |